venBio Global Strategic Fund, L.P.

Insider Reports History

Location
San Francisco, CA
Signature
venBio Global Strategic Fund, L.P., by: venBio Global Strategic GP, L.P., its general partner, by: venBio Global Strategic GP, Ltd., its general partner, by: /s/ David Pezeshki, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by venBio Global Strategic Fund, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Metacrine, Inc. 10%+ Owner Common Stock 2,443,421 $1,148,408 $0.4700 25 Oct 2021 Direct

Insider Reports Filed by venBio Global Strategic Fund, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000156761921018722-venbio-global-strategic-fund-l-p-2021-10-22 Metacrine, Inc. 22 Oct 2021 2 -$928,902 4 10%+ Owner 26 Oct 2021, 16:35